A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole
Status:
Completed
Trial end date:
2018-04-17
Target enrollment:
Participant gender:
Summary
A single dose trial to evaluate the pharmacokinetics of testosterone and anastrozole from
subcutaneous testosterone and anastrozole (T+Ai) in premenopausal women